Press release
Heart Failure Treatment Market Size, Emerging Drugs, Market Outlook, and Companies 2034
heart failure market
Unlock detailed insights into the Heart Failure Market by downloading the comprehensive report from DelveInsight @ Heart Failure Therapeutics Market- https://www.delveinsight.com/sample-request/heart-failure-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr
Key Takeaways from the Heart Failure Market Report
• In October 2024:- Tasly Pharmaceuticals- A Randomized, Placebo-Controlled, Double-Blind and Multi-Centre Phase II Clinical Trial：Efficacy and Safety of Jia Shen Tablets in the Treatment of Coronary Heart Disease Complicating Chronic Heart Failure (Syndrome of Yang Qi Deficiency With Blood Stasis)
• In October 2024:- Boehringer Ingelheim- This study is open to adults aged 18 or above legal age with heart failure. People can join the study if they have heart failure symptoms and a left ventricular ejection fraction (LVEF) of 40% or more. The purpose of this study is to find out whether BI 690517 in combination with empagliflozin helps people with heart failure.
• The increased number of Heart Failure cases, along with the emerging treatment, is likely to contribute directly to the market growth during the forecast period.
• DelveInsight's analysis reveals that the overall diagnosed prevalent population of heart failure in the 7MM was reported as ~15 million in 2022.
• The leading Heart Failure Companies working in the market include Roche, Pfizer, Novo Nordisk, Merck & Co, AstraZeneca, GlaxoSmithKline, Bayer, Bristol-Myers Squibb, Eli Lilly and Company, Novartis, Sanofi, Johnson & Johnson, Takeda Pharmaceutical Company Limited, AbbVie, Gilead Sciences, Amgen, Biogen, Moderna, Regeneron Pharmaceuticals, and Vertex Pharmaceuticals, among others.
• Promising Heart Failure Pipeline Therapies in the various stages of development include PC-61815, Omecamtiv Mecarbil, AZD4831, Rexlemestrocel-L (Revascor), Finerenone (Kerendia), Semaglutide 2.4 mg, Sotagliflozin, Furoscix (furosemide injection), HNO (Nitroxyl) Donor (BMS-986231), Lenrispodun (ITI - 214), Levosimendan, CardiAMPCell Therapy, Tirzepatide, and others.
Gain a competitive edge in the Heart Failure Market by exploring our in-depth analysis. Visit our website to access the full report and make informed strategic decisions @ Heart Failure Treatment Drugs- https://www.delveinsight.com/sample-request/heart-failure-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr
Heart Failure Epidemiology Segmentation in the 7MM
• Total Heart Failure Diagnosed Prevalent Cases
• Heart Failure Gender-specific Cases
• Heart Failure Ejection Fraction-specific 3 Cases
• Heart Failure NYHA Class-specific Cases
• Heart Failure Type-specific Cases
• Heart Failure Age-specific Cases
Download the report to understand which factors are driving Heart Failure Epidemiology trends @ Heart Failure Epidemiological Insights- https://www.delveinsight.com/sample-request/heart-failure-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr
Heart Failure Treatment Market
The primary approach to managing heart failure with reduced ejection fraction (HFrEF) revolves around suppressing neurohormonal activity using various medication classes. Treatment of heart failure should be viewed as an ongoing process. Initially, the focus is on lifestyle adjustments, including quitting smoking, avoiding alcohol and caffeine, reducing stress, limiting fluid intake, and moderating dietary salt. Simultaneously, optimizing essential medical therapies is prioritized.
Heart Failure Therapeutics Market
The management of heart failure relies on several medications such as angiotensin-converting enzyme (ACE) inhibitors, angiotensin receptor II blockers, beta-blockers, and diuretics. Additionally, various treatments including aldosterone antagonists, amiodarone, antiaggregants, anticoagulants, calcium antagonists, diuretics, nitrates, among others, are utilized for addressing heart failure in affected patients. Recently approved therapies for heart failure include Entresto and Corlanor.
Discover key developments and opportunities in the Heart Failure Market. Click here to learn more from DelveInsight's latest report @ Heart Failure Market Size- https://www.delveinsight.com/sample-request/heart-failure-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr
Heart Failure Market Dynamics
The heart failure dynamics market is poised for transformation in the upcoming years. Numerous prominent companies are channeling investments into diverse treatment avenues for congestive heart failure. These include SGLT2 inhibitors, cardiac myosin activators, myeloperoxidase inhibitors, mineralocorticoid receptor antagonists, GLP-1 receptor agonists, cell therapies, and more. Such investments are anticipated to fortify the heart failure market in the years ahead. Additionally, market growth is being propelled by the increasing incidences of cardiovascular diseases (CVDs), rising cases of coronary artery disease, shifts in lifestyle patterns, a surge in smokers, and the escalating prevalence of obesity, diabetes, hypertension, among other factors.
Heart Failure Market Growth
However, several factors could hinder the expansion of the heart failure market. Heart failure is a multifaceted syndrome, and although current treatments can mitigate heart failure risks and slow its progression in certain patients, they are not universally effective. Despite the capability of existing therapies to decelerate disease advancement, there remains a notable unmet medical requirement for patients who continue to deteriorate, even with optimized standard care, as heart failure cannot be cured.
Download DelveInsight's Heart Failure Market report today and stay ahead in this rapidly evolving field. @ Heart Failure Clinical Trials- https://www.delveinsight.com/sample-request/heart-failure-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr
Scope of the Heart Failure Market Report
• Coverage- 7MM
• Study Period- 2019-2032
• Heart Failure Companies- Roche, Pfizer, Novo Nordisk, Merck & Co, AstraZeneca, GlaxoSmithKline, Bayer, Bristol-Myers Squibb, Eli Lilly and Company, Novartis, Sanofi, Johnson & Johnson, Takeda Pharmaceutical Company Limited, AbbVie, Gilead Sciences, Amgen, Biogen, Moderna, Regeneron Pharmaceuticals, and Vertex Pharmaceuticals, among others.
• Heart Failure Pipeline Therapies- PC-61815, Omecamtiv Mecarbil, AZD4831, Rexlemestrocel-L (Revascor), Finerenone (Kerendia), Semaglutide 2.4 mg, Sotagliflozin, Furoscix (furosemide injection), HNO (Nitroxyl) Donor (BMS-986231), Lenrispodun (ITI - 214), Levosimendan, CardiAMPCell Therapy, Tirzepatide, and others.
• Heart Failure Market Dynamics: Heart Failure Market Drivers and Barriers
Discover more about Heart Failure Drugs in development @ Heart Failure Market Drivers and Barriers- https://www.delveinsight.com/sample-request/heart-failure-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr
Table of Content
1. Key Insights
2. Executive Summary of Heart Failure
3. Competitive Intelligence Analysis for Heart Failure
4. Heart Failure: Market Overview at a Glance
5. Heart Failure: Disease Background and Overview
6. Patient Journey
7. Heart Failure Epidemiology and Patient Population
8. Treatment Algorithm, Current Treatment, and Medical Practices
9. Heart Failure Unmet Needs
10. Key Endpoints of Heart Failure Treatment
11. Heart Failure Marketed Products
12. Heart Failure Emerging Therapies
13. Heart Failure: Seven Major Market Analysis
14. Attribute analysis
15. 7MM: Market Outlook
16. Access and Reimbursement Overview of Heart Failure
17. KOL Views
18. Market Drivers
19. Market Barriers
20. Appendix
21. DelveInsight Capabilities
22. Disclaimer
23. About DelveInsight
List of Top Selling Market Research Reports in 2024
• hip replacement devices market - https://www.delveinsight.com/report-store/hip-reconstruction-devices-market
• intraocular lens market- https://www.delveinsight.com/blog/top-companies-in-the-intraocular-lens-market
• diabetic wound market- https://www.delveinsight.com/report-store/diabetic-foot-ulcers-dfus-market
• radial artery compression device market- https://www.delveinsight.com/report-store/radial-artery-compression-devices-market
• sepsis market- https://www.delveinsight.com/report-store/sepsis-market
• spinal implants market- https://www.delveinsight.com/report-store/spinal-implants-market
• transcatheter heart valve replacement devices market- https://www.delveinsight.com/report-store/transcatheter-aortic-valve-replacement-market
• transcatheter treatment market - https://www.delveinsight.com/report-store/transcatheter-treatment-market
• bone growth stimulator market- https://www.delveinsight.com/report-store/bone-growth-stimulators-market
• vascular grafts market- https://www.delveinsight.com/report-store/vascular-grafts-market
• healthcare competitive benchmarking- https://www.delveinsight.com/consulting/competitive-benchmarking-services
• wound healing devices market- https://www.delveinsight.com/report-store/wound-healing-devices-market
• artificial disc market- https://www.delveinsight.com/report-store/artificial-disc-market
• microscopy device market- https://www.delveinsight.com/report-store/microscopy-device-market
• brucellosis market- https://www.delveinsight.com/report-store/brucellosis-market
• healthcare consulting solutions- https://www.delveinsight.com/consulting
• skin neoplasm market- https://www.delveinsight.com/blog/skin-cancer-treatment-market-and-key-companies
• vascular access devices market- https://www.delveinsight.com/report-store/vascular-access-device-market
• myeloproliferative neoplasms market- https://www.delveinsight.com/report-store/myelofibrosis-mf-market
• orthopedic splints device market- https://www.delveinsight.com/report-store/orthotic-devices-market
• total knee arthroplasty market- https://www.delveinsight.com/report-store/knee-reconstruction-devices-market
• lactose intolerance market- https://www.delveinsight.com/report-store/lactose-intolerance-epidemiology-forecast
About Us
DelveInsight is a leading healthcare-focused market research and consulting firm that provides clients with high-quality market intelligence and analysis to support informed business decisions. With a team of experienced industry experts and a deep understanding of the life sciences and healthcare sectors, we offer customized research solutions and insights to clients across the globe. Connect with us to get high-quality, accurate, and real-time intelligence to stay ahead of the growth curve.
Company Name: DelveInsight Business Research LLP
Contact Person: Yash Bhardwaj
Email: ybhardwaj@delveinsight.com
Phone: 09650213330
Address: 304 S. Jones Blvd #2432
City: Las Vegas
State: NV
Country: United States
Website: https://www.delveinsight.com/
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Heart Failure Treatment Market Size, Emerging Drugs, Market Outlook, and Companies 2034 here
News-ID: 3718894 • Views: …
More Releases from DelveInsight Business Research LLP
Genital Warts Pipeline Insights Report 2025 | DelveInsight
DelveInsight's, "Genital Warts Pipeline Insight 2025" report provides comprehensive insights about 30+ companies and 30+ pipeline drugs in Genital Warts pipeline landscape. It covers the Genital Warts pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Explore the comprehensive insights by DelveInsight and stay ahead…
Traumatic Brain Injury Pipeline Drugs Report 2025 | DelveInsight
DelveInsight's "Traumatic Brain Injury Pipeline Insight 2025" report provides comprehensive insights about 20+ companies and 22+ pipeline drugs in Tthe raumatic Brain Injury pipeline landscape. It covers the Traumatic Brain Injury pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Traumatic Brain Injury pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Explore…
Bone Metastasis Pipeline Assessment Report 2025 | DelveInsight
DelveInsight's, "Bone Metastases Pipeline Insight, 2025," report provides comprehensive insights about 10+ companies and 10+ pipeline drugs in Bone Metastases pipeline landscape. It covers the Bone Metastasis pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Bone Metastasis pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Explore the comprehensive insights by DelveInsight…
Acquired Immunodeficiency Syndrome Treatment Market Size Report 2032 | DelveInsi …
DelveInsight's "Acquired Immunodeficiency Syndrome Market Insights, Epidemiology, and Market Forecast-2032′′ report offers an in-depth understanding of the Acquired Immunodeficiency Syndrome, historical and forecasted epidemiology as well as the Acquired Immunodeficiency Syndrome market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
To Know in detail about the Acquired Immunodeficiency Syndrome market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Acquired Immunodeficiency Syndrome Market…
More Releases for Heart
Heart Healthy Foods and Supplements vs Heart Conditions
Heart conditions remain a major health concern worldwide, but the good news is that specific heart healthy foods and supplements can significantly improve cardiovascular health.
Scientific research has demonstrated that certain foods, nutrients and supplements support heart function, reduce inflammation, and lower the risk of heart disease.
Top Heart Healthy Foods
Fatty Fish - Salmon, mackerel, and sardines are rich in omega-3 fatty acids, which help lower blood pressure and reduce inflammation. A…
Centrifugal Heart Pumps Market | Abbott Laboratories, Abiomed, Berlin Heart, Car …
The global centrifugal heart pumps market report is a comprehensive report that provides a detailed analysis of the current status and future trends of the centrifugal heart pumps market worldwide. This report provides valuable information to industry stakeholders by offering an in-depth perspective on market dynamics, competitive landscape, growth opportunities, and key challenges faced by industry participants.
From the perspective of market dynamics, this report explores the factors driving the growth…
Heart disease and Heart Attacks - Kaffailham.gr
Καρδιολόγος Αθηνα - https://kaffailham.gr
When people talk about heart disease or heart attacks. The arteries that they are talking about are the arteries that actually provide blood to the heart. Remember the heart itself is a muscle. It itself needs oxygen. So you have these arteries right over here, the red tubes. Those are arteries. and then the blue ones are veins. They're taking the de-oxygenated blood away from the tissue…
Artificial Heart Implant Market May See a Big Move | Major Giants Jarvik Heart, …
The Latest survey report on Artificial Heart Implant Market sheds lights on changing dynamics of each of the subsegments of Industry. As the shift to value continues, Artificial Heart Implant organizations have the dual challenge of increasing interoperability to improve clinical performance and the patient experience. Some of the companies listed in the study from complete survey list are Medtronic, Boston Scientific, Abbott, Terumo, B.Braun, SynCardia, BiVACOR, CARMAT, ReinHeart TAH…
HEART PUMP DEVICES Market 2020 | SWOT Analysis By Top Players Abbott Laboratorie …
A detailed study on HEART PUMP DEVICES Market formulated by Brandessence Market Research, puts together a concise analysis of the growth factors impacting the current business scenario across assorted regions. Significant information pertaining to the industry's size, share, application, and statistics are also summed in the report in order to present an ensemble prediction. In addition, this report undertakes an accurate competitive analysis illustrating the status of market majors in…
Heart Pump Device Market - Potential Innovations 2025 | Terumo, Jarvik Heart
Heart Pump Device Market: Snapshot
Heart pump devices are essentially mechanical pumps playing the role of ventricular assist devices. These are surgically implanted and are used for temporarily supporting the functions of heart in people with weak heart or irregular blood flow. These devices are notably used as a bridge to cardiac transplantation for patients suffering with end stage heart failure. They can also be used in patients during and after…
